Magazine Konopí
  • Categories
  • Current edition
  • Subscription
  • Sales points
    • Sales points no. 39
    • TRIPACK 2026: Sales locations
    • DUOPACK 2026: Sales locations
  • Archive
  • About us
    • Who we are
    • Editorial
    • Events calendar 2026
    • Advertising
    • Partners
  • Contacts
  • Search
Facebook Instagram LinkedIn YouTube

New cultivation operation in Haná

May 19, 2026 | Category: Therapy
A man with folded arms.

CEO Adam Nastoupil. Source: Geschur Medical

Medical cannabis production facilities are characterized by their close cooperation with experts. This is also evidenced by the company Geschur Medical, whose cultivation facility is located in Horka nad Moravou. We interviewed CEO Adam Nastoupil (AN) and Tibor Béres (TB) from Palacký University, whose specialization is phytochemical analysis of natural substances.

When and why did you decide to start growing cannabis for medicinal use?

TB: The offer to grow medicinal cannabis came during the Covid crisis. Scientists from Palacký University are regularly encouraged to engage in contractual research in addition to primary research. I have always enjoyed that, so I gladly accepted the offer.

How long did it take from the initial idea to the first harvest?

AN: It was definitely not a leap-forward process, but a gradual journey that took several years. From the initial idea, we had to go through both the technological design of the operation and, above all, regulatory preparation, which is essential for medicinal cannabis.

We are currently working on a project related to the valorization of waste from the grow room.

In parallel, we were building a facility that met pharmaceutical standards and setting up processes to be sustainable in the long term. For us, the first harvest was not a beginning, but rather a confirmation that the entire system was working as we intended.

Why Olomouc and how did you get together with scientists from Palacký University?

TB: Olomouc has historically significant moments in modern cannabis treatment. Professors Hanuš, Kabelík, Krejčí and Šantavý were responsible for this. 

AN: The collaboration with Palacký University came about naturally – we knew from the beginning that we didn’t want to go down the path of purely commercial production without a deeper understanding of the plant. On the contrary, we wanted to build the project on data, research, and the ability to systematically evaluate things.

TB: Smaller companies often do not have their own research department and there is a demand for research. Contract research is attractive for the university. So I think the cooperation is based on mutual need. We are currently working together on a project related to the valorization of waste from the grow room. 

What makes you different from other similar medical cannabis producers? 

TB: We strive to produce medicinal cannabis sustainably. Local resources are the key to quality. Among other things, we use high-quality water from the Litovelské Pomoraví Protected Landscape Area for cultivation, and the plants are strong and healthy thanks to the high number of sunny days here in Haná. The powerful LED lighting is powered by solar panels. 

Man cutting a cannabis leaf
Master grower from Palacký University Tibor Beres. Source: Geschur Medical

AN: Our ambition from the beginning was not to be the largest, but to be a consistent and trustworthy producer in the long term. I see the difference mainly in the approach to the entire process. We try to build production in such a way that it is maximally standardized and reproducible over time, not dependent on one successful harvest. 

What are your expectations and ideas regarding the resulting cultivars?

AN: Stability and predictability are our primary requirements. In addition to cannabinoid content, we also monitor the overall quality of the flower, structure, terpene content and processing behavior. 

How long does it take to stabilize a cultivar and what are the pitfalls?

AN: In my opinion, it is important to distinguish between breeding a new cultivar and stabilizing its production. In commercial operations, we primarily work with already stabilized genotypes and focus on ensuring that their properties are consistent within each harvest. The catch is that even small variations in the environment can affect the resulting profile, so the most important work lies in precisely controlling the conditions.

TB: Stabilizing traits can lead to a reduction in potency, so it is not always desirable. The current demand in the medical cannabis field is for genotypes with very high cannabinoid content, so the heterosis effect is used, where the offspring resulting from the crossing of different parents show better traits than both parents, and subsequent vegetative propagation.

What does your offering currently look like in terms of THC and CBD percentages?

TB: We can currently offer genotypes with THC and CBD dominance and also a balanced ratio of them.

AN: We try to remain flexible so that we can respond to the specific demands of the market and individual partners.

Are you going to launch a variety that is completely unique in some way?

AN: Rather than one-off “exceptionalism”, we focus on long-term quality and practical applicability. Of course, we tackle interesting projects and are already working with genetics that go beyond the usual standard. 

Our ambition is not to be the largest, but to be a consistent and trustworthy producer in the long term.

TB: Our exclusive genotype is a cultivar with a balanced ratio of CBD and THC with a specific terpene profile, bred by experts from the St. Anne's University Hospital in Brno.

Can you tell me how much you had to invest?

AN: Entering this industry is capital and time-consuming. It's not just about the cultivation technology itself, but also about meeting regulatory requirements, setting up processes and ensuring quality. I would leave specific numbers aside, but in general, if the project is to operate in the long term and in accordance with the required standards, it is an investment of tens of millions of crowns.

Are you planning to export dry goods to Germany, for example? How do the requirements of the market there differ?

TB: The German market is unique in that it rejects cannabis that has been irradiated with gamma radiation. We prioritize the safety of cannabis use, so we have it sterilized. 

AN: It is crucial for us to be able to guarantee quality in the long term and meet all the partner's requirements before entering a new market. At the moment, we are mainly focused on stabilizing and developing the domestic and regional environment. We see export as a natural next step, but we do not want to rush it.

5 / 5 - (2 votes)
geschur medicalcannabis treatmentmedicinal cannabismedical cannabis cultivationcultivation
avatar photos

Bohumil Sazinka

The super-secret pseudonym of a translator, editor and co-founder of a magazine Konopí, who can thus address various controversial topics and causes without damaging his image as a serious author.

You could be interested in

  • Illustration: Michaela Hoffová Therapy

    The Cannabis Pharmacy of the Future – Part I

  • Source: unsplash.com Therapy

    A scattered world

  • Antibodies attack the tumor cell. Source: Shutterstock Therapy

    The endocannabinoid system and cancer

Write a comment Cancel reply

Latest articles

  • Box and bottle DTOX Drink 10 x 10 ml

    DTOX Drink Box – 10 packs for subscription

    14. November 2026
  • Blocks and boards made of hemp chips and straw displayed on a table with samples of hemp building materials

    Hemp construction at CTU and the use of waste from growing facilities

    13. November 2026
  • Grapes of the vine

    Chirality or mirror forms

    12. November 2026
  • Cooling and warming gel from Hemp Dad

    Cooling or heating? Hemp Dad can do both

    11. November 2026

Follow us!

Facebook YouTube LinkedIn
Follow us on Instagram
ICBC Berlin 2027
  • Advertising
  • Contacts
  • Terms and conditions

HEMP MAGAZINE

The only Czech magazine about cannabis for patients, healthcare professionals and the general public. This year's third issue, No. 39, is available from October 15, 2026 in newsstands and selected post offices throughout the country. Issue 40 will be published on December 10.

Contact: office@konomag.cz

Phone: +420 737 300 375

RUBRICS

  • Readers' letters
  • Editorial
  • Infographics
  • Comments
  • Substances in cannabis
  • Therapy
  • Flying around the world
  • Myths & facts
  • Instructions & recipes
  • Uncategorized
  • Content
  • Cultivation
  • buying guide
  • PR articles
  • Subscriptions & Packages
  • Patient stories
  • For healthcare professionals
  • Reports
  • Interviews
  • Competitions
  • Vaporization
  • Research
  • Laws
  • Animal therapy

NEJNOVĚJŠÍ

  • Box and bottle DTOX Drink 10 x 10 ml

    DTOX Drink Box – 10 packs for subscription

    14. November 2026
  • Blocks and boards made of hemp chips and straw displayed on a table with samples of hemp building materials

    Hemp construction at CTU and the use of waste from growing facilities

    13. November 2026

SEARCH

Watch us

Facebook Instagram LinkedIn

Magazine Konopí

Confirm that you are 18 years old and choose your favorite cannabis cookies
Biscuits are best with Konopím, and ours are very well done! Cookies help us improve the services we offer to our readers, because thanks to completely anonymous crumbs we know what you are craving. So what, will you have some?

By agreeing to the setting of cookies, you also confirm that you are over 18 years old.
Functional Always active
Technical storage or access is essential for the legitimate purpose of enabling the use of a specific service expressly requested by a subscriber or user, or only for the purpose of transmitting a communication over an electronic communications network.
Preferences
Technical storage or access is necessary for the legitimate purpose of storing preferences that are not required by the customer or user.
Statistics
Technical storage or access used exclusively for statistical purposes. Technical storage or access used exclusively for anonymous statistical purposes. Without summons, voluntary performance by your Internet Service Provider, or other third party records, information stored or obtained solely for that purpose cannot normally be used to identify you.
Marketing
Technical storage or access is required to create user profiles in order to advertise or track a user on a website or several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
I will choose
  • {title}
  • {title}
  • {title}